Immunodiagnostic Systems Ids

Immunodiagnostic Systems (IDS) is an established in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields. In 2021, IDS was acquired by Revvity, Inc, joining Euroimmun within the Revvity diagnostics business. Since then, IDS has been gradually integrated into Euroimmun – a leading manufacturer of medical laboratory diagnostics worldwide - to better serve our customers. This integration allows us to combine our expertise and expand our product offerings, providing an even more comprehensive range of high-quality service and diagnostic solutions.